Orchard Therapeutics
ORTX
$16.70
Share price
0.00%
Change (1 day)
244.33%
Change (1 year)
Earnings for Orchard Therapeutics (ORTX)
Earnings in 2023 (TTM): -$73.07 M
According to Orchard Therapeutics 's latest financial reports the company's current earnings (TTM) are -$73.07 M. In 2022 the company made an earning of -$0.16 B a decrease over its 2021 earnings that were of -$0.15 B.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Orchard Therapeutics from 2018 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2023 (TTM) | -$73.07 M | -52.26% |
| 2022 | -$0.16 B | 6.45% |
| 2021 | -$0.15 B | -5.86% |
| 2020 | -$0.16 B | -7.82% |
| 2019 | -$0.17 B | -27.82% |
| 2018 | -$0.23 B |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Organovo ONVO | -$19.09 M | -73.88% | 🇺🇸 USA |
 Orchard Therapeutics
ORTX | -$73.07 M | 0.00% | 🇬🇧 UK |
 Novavax NVAX | -$0.53 B | 623.53% | 🇺🇸 USA |
 Novocure
NVCR | -$0.19 B | 157.90% | Jersey |